信隆健康(002105.SZ):2024年度預虧1000萬元-2000萬元
格隆匯1月22日丨信隆健康(002105.SZ)公佈2024年度業績預吿,2024年歸屬於上市公司股東的淨利潤虧損1,000萬元-2,000萬元,比上年同期減少146.08%-192.15%;扣除非經常性損益後的淨利潤虧損1,400萬元-2,400萬元,比上年同期減少772.82%-1253.40%;基本每股收益虧損0.027元/股-0.054元/股。
報吿期內,公司歸屬於上市公司股東的淨利潤為虧損,主要的原因説明如下:1、主要原材料鋁材價格較上年上升近10%,導致本年度公司綜合銷售毛利較上年有所下降。2、合營企業天騰動力的業務開展不及預期,根據初步測算,公司的長期股年末預計發生減值,減值金額預計約1,000萬元,計提資產減值的最終金額須經公司聘請的評估機構及審計機構進行評估和審計後確定。3、自2023年11月開始,公司至今未收到中洲應支付的龍華廠臨時安置補償款(約2000萬),公司按準則規定無法確認此部分收益,導致利潤相比上年變動較大。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.